| Patient | Cleopatra |
|---|---|
| Date of birth | 1997-01-15 |
| Identifiers | MRN HR-AC003-SYN; SSN (made up) 000-03-7095 |
| Document date | 2026-03-17 |
| Author | Nefeli Arvanitis-Osei, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Prenatal visit at 11 weeks after the first-trimester ultrasound; maternal-fetal medicine consultation today. [S]
Cleopatra returns at 11 weeks 0 days by her last period. This morning's ultrasound with Dr. Haddad-Thornbury of maternal-fetal medicine showed two live fetuses with a thick dividing membrane and a twin-peak sign: a dichorionic diamniotic twin pregnancy. The crown-rump lengths (45 and 46 mm) agree with her dates within three days, so her due date is unchanged. There are no fibroids and no features of a molar pregnancy. The nausea has eased on doxylamine with pyridoxine; she vomits about once a day and keeps food and fluids down (PUQE 7). She takes the prenatal vitamin and ferrous sulfate every other day. She has had no bleeding or pain. She was surprised by the news of twins and is pleased, though she is already thinking about how she will manage her work. Her first-visit results are back. [S]
| Element | Detail |
|---|---|
| Ultrasound | Dichorionic diamniotic twins; dates confirmed; no fibroids or molar features |
| Nausea | Easing; vomits about once a day; PUQE 7 |
| Medicines | Prenatal vitamin, ferrous sulfate every other day, doxylamine with pyridoxine at bedtime |
| Symptoms | No bleeding or pain |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired |
| Gastrointestinal | Positive | Nausea, easing; vomiting about once a day |
| Genitourinary | Negative | No bleeding, discharge, or urinary symptoms |
| Psychiatric | Negative | Surprised and pleased; some worry about work |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Prenatal vitamin containing folic acid 0.4 mg, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-03-03 | active | S |
| Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other day | One tablet every other morning with water or orange juice, apart from tea, coffee, and calcium | Oral route | 2026-03-03 | active | S |
| Doxylamine succinate 10 mg / pyridoxine hydrochloride 10 mg delayed-release tablet, two tablets by mouth at bedtime | Two tablets at bedtime; may add one in the morning if needed | Oral route | 2026-03-03 to 2026-05-12 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-03-17 | Body height | 165 | cm | S |
| 2026-03-17 | Body weight | 58.2 | kg | S |
| 2026-03-17 | Body mass index (BMI) [Ratio] | 21.4 | kg/m2 | S |
| 2026-03-17 | Systolic blood pressure | 106 | mm[Hg] | S |
| 2026-03-17 | Diastolic blood pressure | 64 | mm[Hg] | S |
| 2026-03-17 | Heart rate | 86 | /min | S |
| 2026-03-17 | Respiratory rate | 14 | /min | S |
| 2026-03-17 | Body temperature | 36.6 | Cel | S |
| 2026-03-17 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-17 | Fetal Crown Rump length US | 45 | mm | Consistent with 11 weeks 2 days | Normal | S |
| 2026-03-17 | Fetal Crown Rump length US | 46 | mm | Consistent with 11 weeks 3 days | Normal | S |
| 2026-03-17 | Fetal nuchal translucency measured by US | 1.6 | mm | <=3.5 mm | Normal | S |
| 2026-03-17 | Fetal nuchal translucency measured by US | 1.8 | mm | <=3.5 mm | Normal | S |
Vital signs recorded on 2026-03-17; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well |
| Abdomen | Uterus palpable just above the pubic bone, about 14 weeks in size; non-tender |
| Fetal | Two fetal hearts seen on this morning's scan |
| Urine dipstick | Protein negative; ketones negative |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Uterus larger than dates in early pregnancy: 9 weeks by a certain last menstrual period, with the uterus about 12 to 13 weeks in size; nausea and vomiting heavier than in her first pregnancy; no bleeding; cause not yet known (multiple pregnancy, dating error, fibroids, or molar pregnancy) | resolved | confirmed | O26.841 | S — Synthetic presenting finding anchored to the documented conception in the winter of 41 to 40 BC; it resolves when the ultrasound explains it. |
| Nausea and vomiting of pregnancy, moderate (PUQE score 9); keeping fluids down; no weight loss or ketonuria | active | confirmed | O21.9 | S — Synthetic; nausea is common and often heavier in early pregnancy with a large uterus. |
| Iron deficiency anemia in pregnancy: hemoglobin 10.8 g/dL, MCV 79 fL, ferritin 14 ng/mL | active | confirmed | O99.011 | S — Synthetic finding; it echoes no documented diagnosis. |
| Twin pregnancy, dichorionic diamniotic, second pregnancy (gravida 2, para 1): two live fetuses with a thick dividing membrane and a twin-peak (lambda) sign at 11 weeks; dated by her last period, confirmed by the crown-rump lengths | active | confirmed | O30.041 | S — Synthetic modern diagnosis anchored to the documented twins of 40 BC; chorionicity is a modern finding and makes no claim about her real pregnancy. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Blood pressure and urine protein | Every prenatal visit | Completed today | 106/64 mmHg; urine protein negative |
| Examination | Fetal hearts and fundal height | Every prenatal visit | Completed today | Two live fetuses on the scan; uterus about 14 weeks in size |
| Examination | Weight gain (about 17 to 25 kg for twins from a normal BMI) | Every prenatal visit | Completed today | 58.2 kg, up 0.2 kg since intake |
| Imaging | Dating and chorionicity scan | Before 14 weeks in every twin pregnancy | Completed today | Dichorionic diamniotic; crown-rump lengths 45 and 46 mm; dates confirmed |
| Imaging | Nuchal translucency for each fetus | At 11 to 14 weeks, as she chooses | Completed today | 1.6 mm (twin A) and 1.8 mm (twin B) |
| Laboratory | Cell-free DNA screening | From 10 weeks, as she chooses | Ordered | Drawn today; in twins it cannot say which twin is affected and fails more often |
| Laboratory | First prenatal tests (blood group, antibody screen, rubella, hepatitis B, HIV, syphilis, hepatitis C, urine culture) | At the first prenatal visit | Completed today | Reviewed today: RhD positive; all normal or negative |
| Laboratory | Hemoglobin and ferritin | At intake, at the anatomy-scan visit, at 24 to 28 weeks, and in the third trimester | Up to date | Hemoglobin 10.8 g/dL and ferritin 14 ng/mL at intake; next at 19 weeks |
| Medication safety | Low-dose aspirin | Daily from 12 weeks until delivery; review at every visit | Ordered | Prescribed today to start at 12 weeks |
| Referral | Maternal-fetal medicine consultation | Early in a twin pregnancy | Completed today | Seen today; surveillance plan agreed |
| Imaging | Detailed anatomy scans | At 18 to 22 weeks | Due | Booked for 19 weeks |
| Survey | Perinatal mood screen (EPDS) | Each trimester | Up to date | 6 at intake, item 10 scored 0; next in the second trimester |
| Self-management | Preterm labor warning signs | Every prenatal visit | Completed today | Signs of preterm labor taught; no activity restriction |
Goal progress:
Guideline basis: Multifetal Gestations: Twin, Triplet, and Higher-Order Multifetal Pregnancies: ACOG Practice Bulletin, Number 231 (2021); Prediction and Prevention of Spontaneous Preterm Birth: ACOG Practice Bulletin, Number 234 (2021); Committee Opinion No 700: Methods for Estimating the Due Date (2017); Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226 (2020); Anemia in Pregnancy: ACOG Practice Bulletin, Number 233 (2021); Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication (2021)
Follow-up: Prenatal visit with the anatomy scans at 19 weeks; sooner for bleeding, pain, or vomiting that stops her keeping fluids down. Next scheduled visit 2026-05-12: prenatal visit at 19 weeks with the detailed anatomy scans and cervical length. [S]